Zydus Lifesciences receives USFDA approval for Diroximel Fumarate delayed-release capsules
The approval covers the treatment of relapsing forms of multiple sclerosis in adults, with production to take place at Zydus…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Generic Drugs
Generics gain ground, yet HCPs still favor branded drugs: GlobalData
GlobalData’s survey “Generic Drugs - Physician Perspective” uncovered that if cost was not the primary factor, overall close to 40…
US Supreme Court rebuffs Novartis, allows generic versions of MS drug
Novartis had asked the justices to suspend a lower court's ruling that lifted a ban on generic versions of Gilenya, the…
India to become hub for COVID-19 antiviral generic drugs: Fitch
Increased access to Molnupiravir will keep hospitalisations and deaths in India to a manageable level as Omicron infections rise,…
US House panel approves fourth bill on drug prices
The four measures were part of a package introduced in April to help generic versions of drugs come to market
USFDA gives nod to Cipla’s generic product
According to IQVIA (IMS Health), Durezol had US sales of around $106 million for the 12-month period ending June 2021
The Biden effect on India Pharma Inc
Stakeholders share their views and insights on the impact of a change of guard at the White House and outline India Pharma Inc's…
Generic Aadhaar to launch 20 generic medicines at 50 per cent less price than branded medicines
These medicines will be available at all its Generic Aadhaar stores across the country from October 25
India ramping up API manufacturing: NITI Aayog CEO
The Indian government is committed to achieving its ''Pharma Vision 2020'', which aims to make the country a global leader in drug…
FDA publishes revised MAPP, Consolidation of ANDAs by the Office of Generic Drugs
This MAPP describes the process for reviewing and approving or denying requests to consolidate previously approved ANDAs submitted…